An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo

Journal of Clinical Investigation

Volumn 124, Issue 3, 2014, Pages 1296-1308

  Subramanian, Manikandan ^a   Hayes, Crystal D ^b   Thome, Joseph J ^a,c   Thorp, Edward ^d   Matsushima, Glenn K ^e   Herz, Joachim ^f   Farber, Donna L ^a,c   Liu, Kang ^a   Lakshmana, Madepalli ^b   Tabas, Ira ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXL PROTEIN; CYTOCHALASIN D; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MULTIPROTEIN COMPLEX; PROTEIN TYROSINE KINASE; RAN BINDING PROTEIN 9; RAN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; COCULTURE; CONFOCAL MICROSCOPY; CROSS PRESENTATION; FEMALE; GENE DELETION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; VIRUS LOAD;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CROSS-PRIMING; CYTOSKELETAL PROTEINS; DENDRITIC CELLS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HUMANS; JURKAT CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; NUCLEAR PROTEINS; PHAGOCYTOSIS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, LDL; RECEPTORS, VIRUS; TUMOR SUPPRESSOR PROTEINS;

EID: 84896786643     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI72051     Document Type: Article

References (58)

1. Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL. Modulation of macrophage efferocytosis in inflammation. Front Immunol. 2011;2:57.
2. Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol. 2011;41(9):2515-2518.
3. Scott RS, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001;411(6834):207-211.
4. Cohen PL, et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 2002;196(1):135-140.
5. Lemke G, Lu Q. Macrophage regulation by Tyro 3 family receptors. Curr Opin Immunol. 2003; 15(1):31-36.
6. Hanayama R, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304(5674):1147-1150.
7. Albert ML, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and crosspresent antigens to cytotoxic T lymphocytes. J Exp Med. 1998;188(7):1359-1368.
8. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005;207:166-183.
9. Heath WR, Carbone FR. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol. 2001;1(2):126-134.
10. Nakayama M, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113(16):3821-3830.
11. Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol. 2007;178(9):5635-5642.
12. Schulz O, Pennington DJ, Hodivala-Dilke K, Febbraio M, Reis e Sousa C. CD36 or αvβ3 and αvβ5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8α+ murine dendritic cells. J Immunol. 2002;168(12):6057-6065.
13. Belz GT, et al. CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo. J Immunol. 2002; 168(12):6066-6070.
14. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 2011; 32(8):345-349.
15. Ramirez-Ortiz ZG, et al. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol. 2013;14(9):917-926.
16. Morelli AE, et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood. 2003;101(2):611-620.
17. Iyoda T, et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med. 2002;195(10):1289-1302.
18. Gardai SJ, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through transactivation of LRP on the phagocyte. Cell. 2005; 123(2):321-334.
19. Yancey PG, et al. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscl Thromb Vasc Biol. 2010;30(4):787-795.
20. Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/ alpha 2-macroglobulin receptor. J Biol Chem. 1991;266(31):21232-21238.
21. Qiu C-H, Miyake Y, Kaise H, Kitamura H, Ohara O, Tanaka M. Novel subset of CD8α+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol. 2009;182(7):4127-4136.
22. Bachem A, et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+ CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med. 2010;207(6):1273-1281.
23. Poulin LF, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med. 2010;207(6):1261-1271.
24. Hoffmann PR, et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol. 2001;155(4):649-660.
25. Hafizi S, Gustafsson A, Stenhoff J, Dahlbäck B. The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases. Int J Biochem Cell Biol. 2005;37(11):2344-2356.
26. Lakshmana MK, Yoon I-S, Chen E, Bianchi E, Koo EH, Kang DE. Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid β peptide generation. J Biol Chem. 2009;284(18):11863-11872.
27. Lakshmana MK, et al. Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain. FASEB J. 2012;26(5):2072-2083.
28. Kinchen JM, et al. Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans. Nature. 2005;434(7029):93-99.
29. Su HP, et al. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/Low density lipoprotein receptor-related protein (LRP). J Biol Chem. 2002; 277(14):11772-11779.
30. Ma Z, Nie Z, Luo R, Ravichandran KS. Regulation of Arf6 and ACAP1 signaling by the PTB-domaincontaining adaptor protein GULP. Curr Biol. 2007; 17(8):722-727.
31. Jirmo AC, Nagel C-H, Bohnen C, Sodeik B, Behrens GMN. Contribution of direct and cross-presentation to CTL immunity against Herpes simplex virus 1. J Immunol. 2009;182(1):283-292
32. Mueller SN, Heath W, McLain JD, Carbone FR, Jones CM. Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol Cell Biol. 2002;80(2):156-163.
33. Aita K, Irie H, Koyama AH, Fukuda A, Yoshida T, Shiga J. Acute adrenal infection by HSV-1: role of apoptosis in viral replication. Arch Virol. 2001; 146(10):2009-2020.
34. Bhattacharyya S, et al. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe. 2013;14(2):136-147.
35. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 2007;15(2):243-250.
36. Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol. 2007; 7(10):790-802.
37. Ishimoto Y, Ohashi K, Mizuno K, Nakano T. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem. 2000;127(3):411-417.
38. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLs. Nature. 1998;392(6671):86-89.
39. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol. 2005;174(4):2220-2227.
40. Joffre OP, Segura E, Savina A, Amigorena S. Crosspresentation by dendritic cells. Nat Rev Immunol. 2012;12(8):557-569.
41. Chatterjee B, et al. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood. 2012;120(10):2011-2020.
42. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994; 76(1):17-27.
43. Ahrens S, et al. F-Actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity. 2012;36(4):635-645.
44. Zhang J-G, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity. 2012;36(4):646-657.
45. Iborra S, Izquierdo HM, Martínez-López M, Blanco-Menéndez N, Reis e Sousa C, Sancho D. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest. 2012;122(5):1628-1643.
46. Zelenay S, et al. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virusinfected mice. J Clin Invest. 2012;122(5):1615-1627.
47. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10(1):36-46.
48. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe-/- mice. Arterioscl Thromb Vasc Biol. 2008; 28(8):1421-1428.
49. Ait-Oufella H, et al. Defective Mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscl Thromb Vasc Biol. 2008; 28(8):1429-1431.
50. Yilmaz A, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis. 2004;176(1):101-110.
51. Christ A, Eijgelaar W, Daemen M. The role of dendritic cells in human atherosclerotic lesions. Cardiovasc Res. 2010;87:S129.
52. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005;207:166-183.
53. Camenisch TD, Koller BH, Earp HS, Matsushima GK. A novel receptor tyrosine kinase, Mer, inhibits TNF-α production and lipopolysaccharide- induced endotoxic shock. J Immunol. 1999;162(6):3498-3503.
54. Williams JC, Wagner NJ, Earp HS, Vilen BJ, Matsushima GK. Increased hematopoietic cells in the Mertk-/- mouse peritoneal cavity: A result of augmented migration. J Immunol. 2010;184(12):6637-6648.
55. Rohlmann A, Gotthardt M, Willnow TE, Hammer RE, Herz J. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat Biotech. 1996;14(11):1562-1565.
56. Quah BJC, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc. 2007; 2(9):2049-2056.
57. Blaho JA, Morton ER, Yedowitz JC. Herpes simplex virus: Propagation, quantification, and storage. Curr Protoc Microbiol. 2005;Chapter 14:Unit 14E.1.
58. Chu Y, Wu BM, McCabe ER, Dunn JCY. Serum-free cultures of murine adrenal cortical cells. J Pediatr Surg. 2006;41(12):2008-2012.